ORKA Earnings & Financial Statements
Oruka Therapeutics, Inc.
$76.68
-$1.51(-1.93%)
33
Overall
45
Value
27
Tech
28
Quality
Market Cap
$5.08B
Volume
685.27K
52W Range
$24.46 - $115.52
Target Price
$145.21
ORKA earnings and financial statements: Oruka Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ORKA Annual Financial Statements
| Fiscal year | 2025 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating income | -$122.05M | -$7.30M | -$10.60M | -$19.34M | -$9.77M |
| EBITDA | -$104.40M | -$5.42M | -$10.48M | -$19.24M | -$9.64M |
| Net income | -$105.43M | -$5.34M | -$9.93M | -$19.32M | -$9.74M |
| EPS (diluted) | $-1.85 | $-4.44 | $-8.28 | $-16.68 | $-24.84 |
| Fiscal year | 2025 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total assets | $488.62M | $37.86M | $43.09M | $54.92M | $50.43M |
| Total liabilities | $16.69M | $841.0K | $1.41M | $3.88M | $3.91M |
| Shareholders’ equity | $471.93M | $37.02M | $41.67M | $51.04M | $46.52M |
| Cash and equivalents | $46.94M | $37.43M | $42.45M | $53.36M | $49.07M |
| Long-term debt | $1.31M | $204.0K | $280.0K | $383.0K | $409.0K |
| Fiscal year | 2025 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating cash flow | -$88.21M | -$5.01M | -$10.91M | -$18.76M | -$7.72M |
| Capital expenditure | -$209.0K | - | -$2.0K | -$43.0K | -$19.0K |
| Free cash flow | -$88.42M | -$5.01M | -$10.91M | -$18.80M | -$7.74M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORKA | $76.68 | -1.9% | 685.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oruka Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW